News Reunion Neuroscience to be acquired by MPM BioImpact in US$13.1M deal The deal is expected to close in the third quarter Natalia Buendia CalvilloJune 1, 2023
Stock News Reunion Neuroscience struggles to maintain Nasdaq listing requirements The company has until mid-October to fulfill the requirements before the exchange takes further action Rowan DunneApril 26, 2023
Stock News Reunion Neuroscience starts trading on the TSX Reunion still holds 21.84% interest in Field Trip Health & Wellness Rowan DunneAugust 17, 2022